Teva Rumored To Be In M&A Talks With Mid-sized Korean Pharma
This article was originally published in PharmAsia News
Executive Summary
Predictions of heightened M&A activity among smaller South Korean generic drug firms gained firmer ground this week after an offhand comment by a government official pointed to interest by Teva in a mid-tier firm.